Business & funding

Taiwan’s chipmaking giant TSMC to invest $1B in Anthropic, OpenAI

Latest example of the AI boom’s circular financing comes as AI trade wobbles.

Nvidia shares rebound as Jensen Huang faces scrutiny ahead of earnings

Investors are assessing whether CEO Jensen Huang's affair will have spillover effects on Nvidia's business.

OpenAI’s quarterly revenue reportedly crosses $10B for the first time

Sales of $10 billion represents an almost 50% jump from revenue of $6.7 billion the company recorded in the second quarter.

Anthropic's IPO roadshow video

Anthropic kicked off their IPO roadshow yesterday, and their roadshow video has some previously unreleased information about how their business works. The section on "Approach to compute" with co-founder Tom Brown is…

Arrive AI Announces Strategic Investment in Ottonomy to Accelerate Autonomous Delivery Network Expansion

Deployment agreement contemplates 50 ground robots, with potential for further expansion, building on live operations at Hancock Regional Hospital

US data brokers are selling half a billion dollars in RL training environments to Chinese AI labs

US data brokers like Mercor, Surge AI, and AfterQuery are selling roughly half a billion dollars' worth of AI training data to Chinese labs, according to a ChinaTalk investigation. That includes the same RL environments…

NSF’s X-Labs Program Draws Support From Charities and Investors

When the U.S. National Science Foundation began its X-Labs program in May, the agency said the higher-risk, higher-funded awards would create new kinds of partnerships that would confront urgent scientific and…

Enterprise sales push OpenAI's quarterly revenue to $10 billion, though it still trails Anthropic

OpenAI grew its quarterly revenue 50 percent to $10 billion but is still burning more cash than it brings in. Adjusted operating losses climbed to $10.9 billion, while rival Anthropic operates far more efficiently on…

This Trader Raised Alarm About Nvidia’s China Entanglements Months Ago

Christian Lamarco, a 31-year-old short seller and trader, warned about financial and personal problems at Nvidia in May.

BotPsy: On-Device Personal Assistant with a Sub-Billion-Parameter Agentic Language Model

Anthropic opens Australian retail IPO offering as AI scrutiny intensifies

Anthropic opened its Australia retail IPO offering on Wednesday, allowing individual investors to apply for shares ahead of its planned IPO.

Jim Cramer says Anthropic's explosive growth could justify a record-breaking IPO

"The fact that this deal is on is bullish for tech and the AI trade," CNBC's Jim Cramer said Tuesday.

CoreWeave beats on revenue and lifts guidance, easing AI slowdown concerns

CoreWeave's stock has been hammered heading into the neocloud's Q3 earnings report.

Nvidia sells off for second day in fallout from Jensen Huang’s affair with alleged spy

Investors continue to weigh the potential fallout from CEO Jensen Huang's affair with an alleged Chinese spy.

Amazon and Google Will See Big Paydays from Anthropic IPO

Amazon and Google are the largest investors in the A.I. start-up, and their shares could gain hundreds of billions of dollars in value.

OpenAI acquires Odessia, travel startup created by Sonder founder

OpenAI has not yet said what its plans are for the future of travel. But Sonder founder Francis Davidson is a well-known figure in the travel industry.

All 7 Anthropic founders will each cash out about $250M in IPO

Each of the seven co-founders plans to sell exactly the same number of shares in the IPO, which would bring each of them about $250 million in cash at the midpoint of the price range while leaving the group in control…

Oura to acquire AI-native primary care startup Counsel Health for $625M

The deal comes a few weeks after Oura postponed its up to $2.2 billion IPO indefinitely, citing “uncertainty in the IPO market.”

Claude chatbot maker set for $1.3tn stock market debut despite 'catastrophic' AI warning

The AI company behind the Claude chatbot will offer its shares at between $70 and $78, which is lower than what was expected.

Anthropic Targets Valuation of Up to $1.4 Trillion for Blockbuster I.P.O.

The A.I. company’s pricing would make it one of the biggest ever public listings. It comes at a volatile moment in markets, with investors questioning the sustainability of the A.I. boom.

Anthropic targets valuation of up to $1.4tn in stock market flotation

Claude chatbot developer had been reported to be aiming for $2tn IPO on Wall Street before investors cooled on AIAnthropic is seeking a valuation of up to $1.4tn (£1.1tn) in its imminent stock market flotation, short of…

Anthropic sets IPO price range of $70 to $78, looks to start trading Nov. 19, sources say

Anthropic's IPO is expected to come roughly five months after Elon Musk took SpaceX public in a record offering.

CoreWeave earnings put debt-fueled AI build-out under scrutiny

CoreWeave’s earnings after the bell could calm fears about its debt-fueled AI buildout — or stoke more fear.

Anthropic targets $1.4 trillion IPO

Anthropic confirmed on Tuesday that its IPO could be one of the biggest ever, even while falling short of previous expectations. Its IPO price is expected to be between $70.00 and $78.00 per share, which would put its…

MIT-led team receives funding to develop next-generation alternatives to modern weed killers

With up to $53 million from ARPA-H, the researchers will use AI to generate safer herbicides that reduce dependence on imports and improve the security of the U.S. food supply.

Jim Cramer says Anthropic's IPO could make or break the AI trade. Here's why

Anthropic's initial public offering could be a crucial test of investor confidence in the AI trade, CNBC's Jim Cramer said.

The French fridge hacks were relatively unsophisticated. An AI-enabled attack would raise the stakes

‘Not particularly complex’ defrosting hack has been attributed to Iran, with presumption it is linked to others across EuropeIranian hackers like to send a message.In 2023 a state-backed group interrupted TV streaming…

Anthropic releases first frontier models since Amodei's call for slowdown as IPO buzz builds

The launch comes as Anthropic is gearing up for what is widely expected to be a blockbuster IPO

NVIDIA Announces New Planned Investments in Korean Startups at the MSIT-NVIDIA AI Startup Partnership Forum

Korea’s Ministry of Science and ICT and NVIDIA hosted the MSIT-NVIDIA AI Startup Partnership Forum at COEX. Representatives from the Ministry of Science and ICT and NVIDIA met with over 20 Korean startups across…

OpenAI raises $11B at a $1.25T valuation

Anthropic IPO buyers see valuation as low as $1.1T

Microsoft’s Buyout Offer Sets Its Workforce on Edge

As Microsoft pours billions into artificial intelligence, the company has offered buyouts to about 60,000 employees. The work force was already on edge.

Trump says voters should blame themselves for stock market rout

President Trump said Thursday night that voters had themselves to blame for the stock market's historic sell-off.Why it matters: Two days after Republicans lost the midterm elections in historic fashion, the president…

Franklin Templeton uses OpenAI to support investment research

Starting with equity research, Franklin Templeton is developing AI workflows to help portfolio managers compare research views and examine investment risks.

OpenAI to acquire Pierre Computer Company, Inc.

OpenAI will acquire Pierre Computer Company, expanding Codex’s tools for building, understanding, and reviewing code.

The SEC Should Block Anthropic's IPO to Protect the Public

Anthropic reports $17B in Q3 revenue, commitments of $895B in revised S-1

OpenAI raises less than half of $30B target

Anthropic may not secure investment-grade rating after IPO, Blackstone says

Southeast Asia’s digital economy to hit $368 billion

Widespread AI adoption is propelling Southeast Asia's digital economy to a projected $368 billion in 2026 and $1 trillion by 2035.

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.